EGRX
Eagle Pharmaceuticals, Inc.
EGRX
EGRX
Delisted
EGRX was delisted on the 2nd of October, 2024.
28 hedge funds and large institutions have $143M invested in Eagle Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
28
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$14.5M | |
| 2 | +$4.38M | |
| 3 | +$3.11M | |
| 4 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$2.05M |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$233K |
Top Sellers
| 1 | -$1.26M | |
| 2 | -$707K | |
| 3 | -$372K | |
| 4 |
BPC
Banque Pictet & Cie
Geneva 73,
Switzerland
|
-$167K |
| 5 |
D.E. Shaw & Co
New York
|
-$124K |